Delays in publication of cost utility analyses conducted alongside clinical trials: registry analysis

被引：16
|
作者：
Greenberg, D
Rosen, AB
Olchanski, NV
Stone, PW
Nadai, J
Neumann, PJ
机构：
[1] Harvard Univ, Sch Publ Hlth, Harvard Ctr Risk Anal, Dept Hlth Policy & Management, Boston, MA 02115 USA
[2] Beth Israel Deaconess Med Ctr, Div Gen Med & Primary Care, Boston, MA 02215 USA
[3] Columbia Univ, New York, NY 10032 USA
[4] Massachusetts Gen Hosp, Boston, MA 02114 USA
来源：
BMJ-BRITISH MEDICAL JOURNAL | 2004年 / 328卷 / 7455期
关键词：
D O I：
10.1136/bmj.38079.502326.AE
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1536 / 1537
页数：2
相关论文
共 50 条
  • [41] The Egyptian clinical trials' registry profile: Analysis of three trial registries (International Clinical Trials Registry Platform, Pan-African Clinical Trials Registry and clinicaltrials.gov)
    Zeeneldin, Ahmed A.
    Taha, Fatma M.
    JOURNAL OF ADVANCED RESEARCH, 2016, 7 (01) : 37 - 45
  • [42] TRENDS IN PUBLICATION OF BUDGET IMPACT AND COST UTILITY ANALYSES FROM 2000-2022 IN THE UNITED STATES
    McGarvey, N.
    Duong, A.
    Sarikonda, K.
    Gitlin, M.
    VALUE IN HEALTH, 2024, 27 (06) : S408 - S409
  • [43] Publication bias in trials registered in the Australian New Zealand Clinical Trials Registry: Is it a problem? A cross-sectional study
    Showell, Marian
    Buckman, Sam
    Berber, Slavica
    Allah, Nada Ata
    Patterson, Ben
    Cole, Samantha
    Farquhar, Cynthia
    Jordan, Vanessa
    PLOS ONE, 2023, 18 (01):
  • [44] Predicting survival in cost-effectiveness analyses based on clinical trials
    Gerdtham, UG
    Zethraeus, N
    INTERNATIONAL JOURNAL OF TECHNOLOGY ASSESSMENT IN HEALTH CARE, 2003, 19 (03) : 507 - 512
  • [45] Examining the Clinical Utility of Lacosamide Pooled Analyses of Three Phase II/III Clinical Trials
    Chung, Steve
    Ben-Menachem, Elinor
    Sperling, Michael R.
    Rosenfeld, William
    Fountain, Nathan B.
    Benbadis, Selim
    Hebert, David
    Isojaervi, Jouko
    Doty, Pamela
    CNS DRUGS, 2010, 24 (12) : 1041 - 1054
  • [46] Good research practices for cost-effectiveness analysis alongside clinical trials: The ISPOR RCT-CEA task force report
    Ramsey, S
    Willke, R
    Briggs, A
    Brown, R
    Buxton, M
    Chawla, A
    Cook, J
    Glick, H
    Liljas, B
    Petitti, D
    Reed, S
    VALUE IN HEALTH, 2005, 8 (05) : 521 - 533
  • [47] Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group
    Everest, Louis
    Chen, Bingshu E. E.
    Hay, Annette E. E.
    Cheung, Matthew C. C.
    Chan, Kelvin K. W.
    BMC MEDICAL RESEARCH METHODOLOGY, 2023, 23 (01)
  • [48] Power and sample size calculation for incremental net benefit in cost effectiveness analyses with applications to trials conducted by the Canadian Cancer Trials Group
    Louis Everest
    Bingshu E. Chen
    Annette E. Hay
    Matthew C. Cheung
    Kelvin K. W. Chan
    BMC Medical Research Methodology, 23
  • [49] Osteoporosis Case Manager for Patients With Hip Fractures Results of a Cost-effectiveness Analysis Conducted Alongside a Randomized Trial
    Majumdar, Sumit R.
    Lier, Douglas A.
    Beaupre, Lauren A.
    Hanley, David A.
    Maksymowych, Walter P.
    Juby, Angela G.
    Bell, Neil R.
    Morrish, Donald W.
    ARCHIVES OF INTERNAL MEDICINE, 2009, 169 (01) : 25 - 31
  • [50] A Systematic Analysis of COVID-19 Clinical Trials Registered in the Clinical Trials Registry of India
    Dutta, Siddhartha
    Singhal, Shubha
    Shah, Rima
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (04)
12345